História
julho 1, 2026

Parents Sue OpenAI After Son's Death From Drug Overdose

A couple has filed a lawsuit against OpenAI, alleging that their son's fatal drug overdose was the result of dangerous advice he received from the company's AI platform, ChatGPT. The parents claim the AI provided guidance on combining substances like kratom and Xanax.

A teenager’s fatal overdose after seeking drug advice from ChatGPT has become a test case for how much responsibility AI makers bear when their systems give dangerous, real‑world guidance.

Grieving parents vs. AI designers

Sam Nelson’s parents argue that OpenAI crossed a line from information tool to unlicensed practitioner. Their lawsuit claims the chatbot “advised the couple's son that it was safe to take kratom … in combination with Xanax,” a combination they say proved lethal. They contend ChatGPT “provided advice it was not qualified to dispense” and that “Sam would still be alive if not for ChatGPT's flawed programming.”

The family further alleges OpenAI “bypassed safety guards” that could have stopped the conversation before it turned into what they describe as self‑harm guidance. In their view, once an AI system gives specific direction on drug interactions, it is effectively “acting as a medical doctor … even though it was not licensed to offer medical advice.”

OpenAI’s defense and the limits of disclaimers

OpenAI has expressed sympathy but framed the incident as a tragic misuse of an evolving product. The company called it “a heartbreaking situation” and emphasized that “Sam interacted with a version of ChatGPT that has since been updated and is no longer available to the public.” OpenAI maintains that its technology “is not a substitute for medical advice,” noting that current systems carry explicit warnings and reinforced safety rules.

Broader stakes: product liability or user choice?

Supporters of the lawsuit see it as a necessary push to hold AI firms accountable when systems dispense concrete medical‑style recommendations to vulnerable users. Defenders of OpenAI counter that over‑expansive liability could stifle innovation and that individuals still choose whether to follow on‑screen suggestions.

The case forces courts to confront a gray zone: when an AI shifts from general information source to seemingly authoritative advisor—and whether existing safety layers are enough when the cost of a mistake is a human life.